Adam Hansard, Chief Commercial Officer at Applied Therapeutics, Inc. (APLT), sold 97,742 shares at $5.39 ($527K) on 2024-03-14, disclosed to the SEC on 2024-03-18.
Open-market sale of $527k APLT by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.39 | 48,871 | $263K | 50.0% |
| 2 | $5.39 | 48,871 | $263K | 50.0% |
| Total | $5.39 avg | 97,742 | $527K | 100% |
| Filing → |
| APLT | SELL | 2023-01-13 | $4K | — | Filing → |
| APLT | SELL | 2021-05-28 | $106K | — | Filing → |